[HTML][HTML] Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) …

P Gupta, R Kharbanda, A Lawrence, L Gupta - The Egyptian …, 2021 - Elsevier
Background Anti-melanoma differentiation-associated protein 5 (MDA5) associated
idiopathic inflammatory myopathy (IIM) often manifests with minimal muscle weakness and …

Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated …

P Gupta, R Kharbanda, A Lawrence… - The Egyptian …, 2021 - europepmc.org
Background Anti-melanoma differentiation-associated protein 5 (MDA5) associated
idiopathic inflammatory myopathy (IIM) often manifests with minimal muscle weakness and …

[HTML][HTML] Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) …

P Gupta, R Kharbanda, A Lawrence… - The Egyptian …, 2021 - ncbi.nlm.nih.gov
Background Anti-melanoma differentiation-associated protein 5 (MDA5) associated
idiopathic inflammatory myopathy (IIM) often manifests with minimal muscle weakness and …

Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated …

P Gupta, R Kharbanda… - The Egyptian …, 2021 - research.manchester.ac.uk
BACKGROUND: Anti-melanoma differentiation-associated protein 5 (MDA5) associated
idiopathic inflammatory myopathy (IIM) often manifests with minimal muscle weakness and …

Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated …

P Gupta, R Kharbanda… - The Egyptian …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Anti-melanoma differentiation-associated protein 5 (MDA5) associated
idiopathic inflammatory myopathy (IIM) often manifests with minimal muscle weakness and …